Literature DB >> 2148081

Inhibition of African swine fever virus in cultured swine monocytes by phosphonoacetic acid (PAA) and by phosphonoformic acid (PFA).

F Villinger1, E V Genovesi, D J Gerstner, T C Whyard, R C Knudsen.   

Abstract

The use of phosphonoacetic (PAA) and phosphonoformic acid (PFA) as inhibitors of African swine fever virus (ASFV) replication in porcine monocytes/macrophages (MO) was investigated. At concentrations sufficient to inhibit replication, hemadsorption, and cytopathogenic damage by high inocula of ASFV, both antiviral agents were cytostatic and suppressed the DNA-synthetic growth response of porcine MO to the MO-specific colony-stimulating factor-1 (CSF-1). PAA and PFA inhibited ASFV-associated DNA-synthesis in the cytoplasm of infected swine MO. Using ASFV-specific monoclonal antibodies in immunebinding assays and in immunoprecipitation analysis of radiolabeled proteins of infected MO, PAA and PFA inhibited the synthesis of ASFV proteins of 13, 73, and 150/220 kDa, and caused a variable inhibition in the synthesis of a 12 kDa ASFV protein. These antiviral drugs, however, did not prevent the appearance of an early 32 kDa ASFV protein. The cytostatic and virus-suppressive effects of PAA and PFA could be reversed. ASFV resumed growth in infected MO cultures, if the cells maintained in medium with CSF-1 were removed from the antivirals before 1 week of drug exposure. With prolonged exposure to PAA or PFA (beyond 1 week), ASFV could not be recovered from infected MO cultures.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148081     DOI: 10.1007/bf01310528

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  60 in total

1.  PROPAGATION AND MODIFICATION OF AFRICAN SWINE FEVER VIRUS IN CELL CULTURES.

Authors:  W R HESS; B F COX; W P HEUSCHELE; S S STONE
Journal:  Am J Vet Res       Date:  1965-01       Impact factor: 1.156

2.  Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.

Authors:  J M Reno; L F Lee; J A Boezi
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

3.  Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.

Authors:  S Alenius; Z Dinter; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

Review 4.  The antiherpesvirus action of phosphonoacetate.

Authors:  J A Boezi
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

5.  Characterization of African swine fever virus antigenic proteins by immunoprecipitation.

Authors:  G J Letchworth; T C Whyard
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

6.  Reversible effects on cellular metabolism and proliferation by trisodium phosphonoformate.

Authors:  K Stenberg; A Larsson
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

7.  African swine fever virus DNA: restriction endonuclease cleavage patterns of wild-type, Vero cell-adapted and plaque-purified virus.

Authors:  R D Wesley; I C Pan
Journal:  J Gen Virol       Date:  1982-12       Impact factor: 3.891

8.  In vitro induction of swine peripheral blood monocyte proliferation by the fibroblast-derived murine hematopoietic growth factor CSF-1.

Authors:  E V Genovesi; R C Knudsen; D J Gerstner; D M Card; C L Martins; J C Quintero; T C Whyard
Journal:  Vet Immunol Immunopathol       Date:  1989-12       Impact factor: 2.046

9.  Mode of action of phosphonoformate as an anti-herpes simplex virus agent.

Authors:  Y C Cheng; S Grill; D Derse; J Y Chen; S J Caradonna; K Connor
Journal:  Biochim Biophys Acta       Date:  1981-01-29

10.  Inhibition of African swine fever virus DNA synthesis by (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine.

Authors:  O Arzuza; D García-Villalón; E Tabarés; C Gil-Fernández; E De Clercq
Journal:  Biochem Biophys Res Commun       Date:  1988-07-15       Impact factor: 3.575

View more
  1 in total

1.  Expression in vivo and in vitro of the major structural protein (VP73) of African swine fever virus.

Authors:  C Cistué; E Tabarés
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.